29 Nov 2019 11:00
29 November 2019
Kainos Group plc
("Kainos" or the "Company")Β
Total Voting Rights
Pursuant to DTR 5.6.1 the Company announces that as at 29 November 2019, the total number of ordinary shares in issue now stands at 121,517,631 each with voting rights. There are no shares held in treasury.
Β
The above figure (121,517,631) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the Company under the FCA's Disclosure and Transparency Rules.
Β
Kainos Group plc Legal Entity Identifier: 213800H2PQMIF3OVZY47Β
Classification: 2.5 - Total number of voting rights and capital
Β
Ends
Β
For further information, please contact:
Β
Kainos via FTI Consulting LLP
Brendan Mooney, Chief Executive Officer
Richard McCann, Chief Financial Officer
Β
Investec Bank plc +44Β 20 7597 5970
Patrick Robb / Sebastian Lawrence
Β
Canaccord Genuity Limited +44 20 7523 4606
Simon Bridges / Andrew Potts
Β
FTI Consulting LLP +44 20 3727 1000
Matt Dixon / Leah Dudley
Β
About Kainos
KainosΒ Group plc is a UK-headquartered provider of Digital Services and Digital Platforms.Β
Β
The Group's Digital Services include full lifecycle development and support ofΒ customisedΒ Digital Services for government and commercial customers.Β KainosΒ is also the leading European partner for Workday, Inc. ('Workday'), responsible for implementing Workday's innovative Software-as-a-Service (SaaS) platform for enterprise and, now, government customers.Β
Β
The Group's Digital Platforms compriseΒ specialisedΒ digital platforms in the mobile healthcare and automated testing arenas. Smart is an automated testing platform for Workday customers; Evolve Electronic Medical Records ('EMR') is the market-leading product for theΒ digitisationΒ of patient notes in the Acute sector of the NHS.
Β
Kainos has over 1,470Β people across 12 offices in Europe and North America.Β
Β
KainosΒ is listed on the London Stock Exchange (LSE: KNOS). For further information, please visitΒ www.kainos.com.
Follow the stocks